Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Start Date
9/11/2026
Completion Date
4/1/2041
Summary
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Detailed Description
Prospective, global, pre-market, interventional, multi-center, randomized controlled pivotal trial to evaluate the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System compared to Edwards EVOQUE TTVR System in symptomatic patients with severe or greater tricuspid regurgitation.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Conditions
Locations
University of Alabama at Birmingham (UAB) Hospital
Birmingham, Alabama 35233
United States
Abrazo Arizona Heart Hospital
Phoenix, Arizona 85016
United States
Los Robles Hospital & Medical Center
Thousand Oaks, California 91360
United States
Yale New Haven Hospital
New Haven, Connecticut 06510
United States
Emory University Hospital Midtown
Atlanta, Georgia 30308
United States
Northwestern Memorial Hospital
Chicago, Illinois 60611
United States
Abbott Northwestern Hospital
Minneapolis, Minnesota 55407
United States
Buffalo General Medical Center
Buffalo, New York 14203
United States
Northwell Health North Shore University Hospital
Manhasset, New York 11030
United States
NYU Langone Medical Center
New York, New York 10016
United States
Montefiore Medical Center
New York, New York 10467
United States
The Christ Hospital
Cincinnati, Ohio 45219
United States
Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States